Holen Sie sich die Stockscreener-App
155.96
2.26%
3.5407
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$152.42
Offen:
$153
24-Stunden-Volumen:
347.54K
Relative Volume:
0.35
Marktkapitalisierung:
$10.42B
Einnahmen:
$13.64B
Nettoeinkommen (Verlust:
$1.05B
KGV:
16.32
EPS:
9.555
Netto-Cashflow:
$1.31B
1W Leistung:
+5.22%
1M Leistung:
+2.40%
6M Leistung:
+21.75%
1J Leistung:
+12.19%
1-Tages-Spanne:
$153.00
$156.15
1-Wochen-Bereich:
$146.60
$156.15
52-Wochen-Spanne:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
155.94 | 10.02B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
475.85 | 105.34B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
188.67 | 16.25B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.74 | 12.54B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
189.09 | 11.20B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
181.34 | 10.90B | 17.36B | 1.51B | 849.25M | 23.15 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
What’s So Good About DaVita (DVA) That Warren Buffett Remains Bullish On It Since 15 Years? - Yahoo Finance UK
Here's why you should retain DaVita stock in your portfolio for now - MSN
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
What to Expect From DaVita's Next Quarterly Earnings Report - Barchart.com
Outpatient & Specialty Care Stocks Q4 Earnings Review: DaVita (NYSE:DVA) Shines - Yahoo Finance
Lobbying Update: $1,200,000 of DAVITA INC lobbying was just disclosed - Quiver Quantitative
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call - The Malaysian Reserve
DaVita (DVA) Stock: Support and Resistance Zones (Touches High) 2026-04-20Retail Picks - Cổng thông tin điện tử tỉnh Tây Ninh
DaVita Inc stock (US23804L1035): Is its dialysis network dominance the real long-term edge? - AD HOC NEWS
Kidney Dialysis Equipment Market Is Booming So Rapidly| Davita - openPR.com
DaVita Inc. (DVA) Stock Analysis: Navigating Growth With A 64.85% Return On Equity - DirectorsTalk Interviews
DaVita Inc stock (US23804L1035): Why Google Discover changes matter more now - AD HOC NEWS
DaVita Clinical Research Celebrates Milestone Year - Yahoo
KBC Group NV Raises Position in DaVita Inc. $DVA - MarketBeat
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc (DVA) Shares Fall 3.3% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): Is kidney care demand strong enough to drive steady investor retur - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock rises Monday, still underperforms market - MarketWatch
DaVita Inc stock (US23804L1035): Why its kidney care dominance matters more now for investors - AD HOC NEWS
DaVita Inc. (DVA) Is Down 9% This Year. Here Is Why - MSN
Will DaVita’s (DVA) Push Into Patient-Centric Data Access Reshape Its Digital Health Narrative? - Sahm
Assessing DaVita (DVA) Valuation After Earnings Beat Buyback Debate And EPS Guidance Questions - Yahoo Finance
DaVitaFurther Upside Is Trickier (Rating Downgrade) (NYSE:DVA) - Seeking Alpha
Aberdeen Group plc Has $230,000 Stake in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock (US23918K1088): Is its dialysis dominance strong enough to unlock new upside? - AD HOC NEWS
DaVita HealthCare (DVA) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Reasons to Keep DaVita Stock in Your Investment Portfolio at This Time - Bitget
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Eastern Progress
Zacks Downgrades DaVita Stock Rating - National Today
DaVita Inc stock: What investors need to know about its dialysis dominance now - AD HOC NEWS
California law limiting dialysis providers' profits voided by US appeals court - Reuters
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Day in the Life: Ansel, DaVita Home Hemodialysis Registered Nurse - CSRwire
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - csrwire.com
Day in the Life: Jena, DaVita Social Worker - CSRwire
Day in the Life: Cristina, DaVita PD Registered Nurse - CSRwire
DVA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
DaVita Inc. stock underperforms Thursday when compared to competitors - MSN
DaVita Inc. (DVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Inc. (DVA.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada
DaVita Entities’ Drug Purchases Exempt From Louisiana Sales Tax - news.bloombergtax.com
DaVita Inc. stock: Steady earnings beat amid market dips—what's next? - AD HOC NEWS
DaVita Arms Freed From Local La. Tax On Medicare Drugs - Law360
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):